Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Elie Rassy & Nicholas Pavlidis. (2020) The diagnostic challenges of patients with carcinoma of unknown primary. Expert Review of Anticancer Therapy 20:9, pages 775-783.
Read now
Read now
Chong S. Kim, Malek B. Hannouf, Sisira Sarma, George B. Rodrigues, Peter K. Rogan, Salaheddin M. Mahmud, Eric Winquist, Muriel Brackstone & Gregory S. Zaric. (2015) Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada. Acta Oncologica 54:10, pages 1781-1787.
Read now
Read now
Odd Terje Brustugun & Åslaug Helland. (2014) Rapid reduction in the incidence of cancer of unknown primary. A population-based study. Acta Oncologica 53:1, pages 134-137.
Read now
Read now
Anne Kirstine Hundahl Møller, Karen Damgaard Pedersen, Anita Gothelf & Gedske Daugaard. (2010) Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study. Acta Oncologica 49:4, pages 423-430.
Read now
Read now
Articles from other publishers (42)
Sakura Sakakibara, Laura Pazzagli & Marie Linder. (2024) Consistency between the National Patient Register and the Swedish Cancer Register. Pharmacoepidemiology and Drug Safety 33:4.
Crossref
Crossref
Mohamed A. Gouda, Blessie E. Nelson, Lars Buschhorn, Adam Wahida & Vivek Subbiah. (2023) Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications. Clinical Cancer Research 29:15, pages 2753-2760.
Crossref
Crossref
Beatrice Gadiel Mathew, Fine Aliyuda, Denis Taiwo, Kehinde Adekeye, Godwin Agada, Elisabet Sanchez, Aruni Ghose, Elie Rassy & Stergios Boussios. (2023) From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary. International Journal of Molecular Sciences 24:6, pages 5588.
Crossref
Crossref
Julie A. Bytnar, Jie Lin, Joel T. Moncur, Craig D. Shriver & Kangmin Zhu. (2023) Cancers of unknown primary: Survival by histologic type, demographic features, and treatment in the U.S. Military Health System. Cancer Epidemiology 82, pages 102316.
Crossref
Crossref
Peng Qi, Yifeng Sun, Xin Liu, Sheng Wu, Yixin Wo, Qinghua Xu, Qifeng Wang, Xichun Hu & Xiaoyan Zhou. (2022) Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases. Cancer Medicine 12:2, pages 1177-1188.
Crossref
Crossref
Atsuko Sugimoto, Kanae Nakamura, Kousuke Kuwahara, Noriko Matsumoto, Kotoho Oki & Rei Ogawa. (2022) Squamous Cell Carcinoma of Unknown Primary that Metastasized to an Inguinal Lymph Node: A Case Report. Journal of Nippon Medical School 89:4, pages 454-459.
Crossref
Crossref
Yoo-Kyung Boo, Dayeon Park, Jiwon Lim, Hyun-Sook Lim & Young-Joo Won. (2021) Descriptive epidemiology of cancer of unknown primary in South Korea, 1999–2017. Cancer Epidemiology 74, pages 102000.
Crossref
Crossref
Christina Große-Thie, Claudia Maletzki, Christian Junghanss & Kathie Schmidt. (2021) Long-term survivor of metastatic squamous-cell head and neck carcinoma with occult primary after cetuximab-based chemotherapy: A case report. World Journal of Clinical Cases 9:24, pages 7092-7098.
Crossref
Crossref
Timothée Olivier, Eugenio Fernandez, Intidhar Labidi-Galy, Pierre-Yves Dietrich, Veronica Rodriguez-Bravo, Giulia Baciarello, Karim Fizazi & Anna Patrikidou. (2021) Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?. Cancer Treatment Reviews 97, pages 102204.
Crossref
Crossref
Yoshinobu Ishiwata, Tomohiro Kaneta, Shintaro Nawata, Hitoshi Iizuka & Daisuke Utsunomiya. (2020) Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET/computed tomography images of largest metastatic lymph node. Nuclear Medicine Communications 42:1, pages 86-92.
Crossref
Crossref
Michael S Lee & Hanna K Sanoff. (2020) Cancer of unknown primary. BMJ, pages m4050.
Crossref
Crossref
Elie Rassy & Nicholas Pavlidis. (2020) Progress in refining the clinical management of cancer of unknown primary in the molecular era. Nature Reviews Clinical Oncology 17:9, pages 541-554.
Crossref
Crossref
G. R. Boeckel, M. Pouyiourou, L. Claßen, T. Bochtler & A. Krämer. (2020) Diagnostik und Therapie von Krebserkrankungen mit unbekanntem Primärtumor (CUP-Syndrom)Diagnostic and treatment of cancer of unknown primary site (CUP syndrome). best practice onkologie 15:3, pages 76-84.
Crossref
Crossref
Haeyoung Kim, Won Park, Su Ssan Kim, Sung Ja Ahn, Yong Bae Kim, Tae Hyun Kim, Jin Hee Kim, Jin-Hwa Choi, Hae Jin Park, Jee Suk Chang & Doo Ho Choi. (2020) Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI. The Breast 49, pages 63-69.
Crossref
Crossref
N. Jung, W.-J. Mayet, P.R. Mertens, J. Meyer (federführend)O.-A. Müller, M. Pfeifer, P. Schellinger, N. Weiss & C.-M. Wendtner. 2020. Rationelle Diagnostik und Therapie in der Inneren Medizin. Rationelle Diagnostik und Therapie in der Inneren Medizin
B-1
B30-3
.
Elie Rassy & Nicholas Pavlidis. (2019) The currently declining incidence of cancer of unknown primary. Cancer Epidemiology 61, pages 139-141.
Crossref
Crossref
C.M. Vajdic, O. Perez-Concha, J.J. Rhee, T. Dobbins, R.L. Ward, A.L. Schaffer, M.T. van Leeuwen, M.A. Laaksonen, G. Craigen & S.A. Pearson. (2019) Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP). Cancer Epidemiology 61, pages 1-7.
Crossref
Crossref
C.M. Vajdic, O. Perez-Concha, T. Dobbins, R.L. Ward, A.L. Schaffer, M.T. van Leeuwen, J.J. Rhee, M.A. Laaksonen, G. Craigen & S.A. Pearson. (2019) Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP). Cancer Epidemiology 60, pages 156-161.
Crossref
Crossref
Carmen Binder, Katarina Luise Matthes, Dimitri Korol, Sabine Rohrmann & Holger Moch. (2018) Cancer of unknown primary—Epidemiological trends and relevance of comprehensive genomic profiling. Cancer Medicine 7:9, pages 4814-4824.
Crossref
Crossref
Christian Lorentz. 2018. Geriatrische Onkologie. Geriatrische Onkologie
583
587
.
William Jones, Gwen Allardice, Iona Scott, Karin Oien, David Brewster & David S. Morrison. (2017) Cancers of unknown primary diagnosed during hospitalization: a population-based study. BMC Cancer 17:1.
Crossref
Crossref
Klaus Kraywinkel & Sylke Ruth Zeissig. (2017) Epidemiologie des CUP-Syndroms in DeutschlandEpidemiology of CUP syndrome in Germany. Der Onkologe 23:12, pages 966-973.
Crossref
Crossref
Christian Lorentz. 2017. Geriatrische Onkologie. Geriatrische Onkologie
1
5
.
Eiji Nakamura, Takeshi Oda, Hiroshi Yasunaga & Shigeaki Aoyagi. (2016) A Case of Femoral Arterial Bleeding by an Unknown Origin Metastatic Groin Lymph Nodes Carcinoma. Annals of Vascular Diseases 9:1, pages 62-65.
Crossref
Crossref
Kari Hemminki. 2016. Cancer of Unknown Primary. Cancer of Unknown Primary
5
25
.
Eri Oda, Daisuke Hashimoto, Yuko Shiomi, Koji Ohnishi, Hiromitsu Hayashi, Akira Chikamoto, Motohiro Takeya & Hideo Baba. (2015) A case of occult intrahepatic cholangiocarcinoma diagnosed by autopsy. Surgical Case Reports 1:1.
Crossref
Crossref
Gerdt Hübner. 2015. SpringerReference Innere Medizin. SpringerReference Innere Medizin
1
15
.
Matias Riihimäki, Akseli Hemminki, Kristina Sundquist & Kari Hemminki. (2014) Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site. BMC Cancer 14:1.
Crossref
Crossref
Rudolf Kaaks, Disorn Sookthai, Kari Hemminki, Alwin Krämer, Heiner Boeing, Elisabet Wirfält, Elisabete Weiderpass, Kim Overvad, Anne Tjønneland, Anja Olsen, Petra H. Peeters, H. B(as) Bueno‐de‐Mesquita, Salvatore Panico, Valeria Pala, Paolo Vineis, J. Ramón Quirós, Eva Ardanaz, María‐José Sánchez, Maria‐Dolores Chirlaque, Nerea Larrañaga, Paul Brennan, Dimitrios Trichopoulos, Antonia Trichopoulou, Pagona Lagiou, Göran Hallmans, Kay‐Tee Khaw, Timothy J. Key, Elio Riboli & Federico Canzian. (2014) Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort. International Journal of Cancer 135:10, pages 2475-2481.
Crossref
Crossref
David H. Brewster, Jaroslaw Lang, Lesley A. Bhatti, Catherine S. Thomson & Karin A. Oien. (2014) Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961–2010. Cancer Epidemiology 38:3, pages 227-234.
Crossref
Crossref
Matias Riihimäki, Hauke Thomsen, Akseli Hemminki, Kristina Sundquist & Kari Hemminki. (2013) Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer. BMC Cancer 13:1.
Crossref
Crossref
Margareta Randén, Maria Helde-Frankling, Sara Runesdotter & Peter Gunvén. (2013) Unfavorable cancers of unknown primaries: presentation and prognostic factors. A population-based 8-year experience. Medical Oncology 30:4.
Crossref
Crossref
D Urban, A Rao, M Bressel, Y R Lawrence & L Mileshkin. (2013) Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. British Journal of Cancer 109:5, pages 1318-1324.
Crossref
Crossref
M. Riihimäki, A. Hemminki, K. Sundquist & K. Hemminki. (2013) Time trends in survival from cancer of unknown primary: Small steps forward. European Journal of Cancer 49:10, pages 2403-2410.
Crossref
Crossref
Kari Hemminki, Matias Riihimäki, Kristina Sundquist & Akseli Hemminki. (2013) Site‐specific survival rates for cancer of unknown primary according to location of metastases. International Journal of Cancer 133:1, pages 182-189.
Crossref
Crossref
Hao Liu, Kari Hemminki, Jan Sundquist, Bernd Holleczek, Alexander Katalinic, Katharina Emrich & Hermann Brenner. (2013) Second primary cancers after cancer of unknown primary in Sweden and Germany. European Journal of Cancer Prevention 22:3, pages 210-214.
Crossref
Crossref
G. Hübner. (2012) CUP-SyndromCUP syndrome. Der Onkologe 19:1, pages 8-14.
Crossref
Crossref
Eric Yaovi Amela, Géraldine Lauridant-Philippin, Sophie Cousin, Thomas Ryckewaert, Antoine Adenis & Nicolas Penel. (2012) Management of “unfavourable” carcinoma of unknown primary site: Synthesis of recent literature. Critical Reviews in Oncology/Hematology 84:2, pages 213-223.
Crossref
Crossref
K. Hemminki, M. Bevier, A. Hemminki & J. Sundquist. (2012) Survival in cancer of unknown primary site: population-based analysis by site and histology. Annals of Oncology 23:7, pages 1854-1863.
Crossref
Crossref
K. Hemminki, H. Liu, A. Heminki & J. Sundquist. (2012) Power and limits of modern cancer diagnostics: cancer of unknown primary. Annals of Oncology 23:3, pages 760-764.
Crossref
Crossref
X. Shu, H. Liu, J. Ji, K. Sundquist, A. Försti, J. Sundquist & K. Hemminki. (2012) Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?. Annals of Oncology 23:1, pages 269-275.
Crossref
Crossref
Kari HemminkiJianguang JiJan SundquistXiaochen Shu. (2011) Familial Risks in Cancer of Unknown Primary: Tracking the Primary Sites. Journal of Clinical Oncology 29:4, pages 435-440.
Crossref
Crossref